STTK

Shattuck Labs, Inc.

8.68 USD
-0.31 (-3.45%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Shattuck Labs, Inc. stock is down -8.54% since 30 days ago. The next earnings date is May 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 7 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 10 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 Jan 18:42 16 Feb, 2024 10.00 CALL 200 13
08 Jan 19:03 16 Feb, 2024 10.00 CALL 199 13
08 Jan 19:05 19 Jan, 2024 5.00 CALL 219 484
10 Jan 17:50 21 Jun, 2024 5.00 CALL 100 128
12 Jan 18:22 19 Jan, 2024 7.50 CALL 110 3114
12 Jan 19:48 19 Jan, 2024 7.50 CALL 499 3114
17 Jan 14:47 19 Jan, 2024 2.50 CALL 50 188
19 Jan 18:08 16 Feb, 2024 12.50 CALL 500 313
22 Jan 14:41 16 Feb, 2024 10.00 CALL 300 371
16 Feb 19:58 15 Mar, 2024 12.50 CALL 790 118

About Shattuck Labs, Inc.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company was incorporated in 2016 and is headquartered in Austin, Texas.

  • HC Wainwright & Co.
    Tue Feb 13, 12:31
    buy
    confirm
  • Needham
    Tue Feb 13, 09:36
    buy
    confirm